"1210-7859" . "Epidemiological studies have shown a higher incidence of diabetes in patients with schizophrenia. It is assumed that this is caused by many factors. Genetic factors for schizophrenia and diabetes are instable, but other factors can influence. These include in particular an antipsychotic medication and lifestyle of patients. More problematic antipsychotics clozapine and olanzapine are less risky amisulpride, aripiprazole, sertindole and ziprasidone. What is important is the possibility of developing diabetes and other think and periodically during treatment of schizophrenia monitor blood glucose and other parameters, such as body mass index, plasma lipids, blood pressure and pulse, and in addition, try to educate patients about healthy lifestyles."@en . . "Ustohal, Libor" . "P(ED1.1.00/02.0068), V, Z(MSM0021622404)" . . . "Diabetes a schizofrenie" . "Diabetes a schizofrenie" . . . . "Diabetes a schizofrenie"@cs . "Diabetes a schizofrenie"@cs . . "schizophrenia"@en . . "CZ - \u010Cesk\u00E1 republika" . "4"^^ . "Diabetes and schizophrenia"@en . . "Epidemiologick\u00E9 studie prok\u00E1zaly signifikantn\u011B vy\u0161\u0161\u00ED v\u00FDskyt diabetu u pacient\u016F se schizofreni\u00ED ne\u017E v b\u011B\u017En\u00E9 populaci. P\u0159edpokl\u00E1d\u00E1 se, \u017Ee je to zp\u016Fsobeno \u0159adou faktor\u016F. N\u011Bkter\u00E9 z nich, jako nap\u0159. genetick\u00E9 faktory pro schizofrenii a diabetes, jsou neovlivniteln\u00E9, jin\u00E9 ale ovlivnit lze. Pat\u0159\u00ED k nim zejm\u00E9na antipsychotick\u00E1 medikace a \u017Eivotn\u00ED styl pacient\u016F. Z tohoto \u00FAhlu pohledu se jev\u00ED jako v\u00EDce problematick\u00E1 antipsychotika klozapin a olanzapin, naopak za m\u00E9n\u011B rizikov\u00E9 se pova\u017Euj\u00ED amisulprid, aripiprazol, sertindol a ziprasidon. D\u016Fle\u017Eit\u00E9 js na mo\u017Enost rozvoje diabetu a dal\u0161\u00EDch kardiometabolick\u00FDkch komplikac\u00ED myslet a pravideln\u011B v pr\u016Fb\u011Bhu l\u00E9\u010Dby schizofrenie sledovat glykemii a dal\u0161\u00ED parametry, jako jsou body mass index, lipidemie, krevn\u00ED tlak a pulz a krom\u011B toho se sna\u017Eit edukovat pacienty o zdrav\u00E9m \u017Eivotn\u00EDm stylu." . "\u010Cesk\u00E1 a slovensk\u00E1 neurologie a neurochirurgie" . . . "RIV/65269705:_____/12:#0001705" . "130906" . "RIV/65269705:_____/12:#0001705!RIV13-MZ0-65269705" . . "Epidemiologick\u00E9 studie prok\u00E1zaly signifikantn\u011B vy\u0161\u0161\u00ED v\u00FDskyt diabetu u pacient\u016F se schizofreni\u00ED ne\u017E v b\u011B\u017En\u00E9 populaci. P\u0159edpokl\u00E1d\u00E1 se, \u017Ee je to zp\u016Fsobeno \u0159adou faktor\u016F. N\u011Bkter\u00E9 z nich, jako nap\u0159. genetick\u00E9 faktory pro schizofrenii a diabetes, jsou neovlivniteln\u00E9, jin\u00E9 ale ovlivnit lze. Pat\u0159\u00ED k nim zejm\u00E9na antipsychotick\u00E1 medikace a \u017Eivotn\u00ED styl pacient\u016F. Z tohoto \u00FAhlu pohledu se jev\u00ED jako v\u00EDce problematick\u00E1 antipsychotika klozapin a olanzapin, naopak za m\u00E9n\u011B rizikov\u00E9 se pova\u017Euj\u00ED amisulprid, aripiprazol, sertindol a ziprasidon. D\u016Fle\u017Eit\u00E9 js na mo\u017Enost rozvoje diabetu a dal\u0161\u00EDch kardiometabolick\u00FDkch komplikac\u00ED myslet a pravideln\u011B v pr\u016Fb\u011Bhu l\u00E9\u010Dby schizofrenie sledovat glykemii a dal\u0161\u00ED parametry, jako jsou body mass index, lipidemie, krevn\u00ED tlak a pulz a krom\u011B toho se sna\u017Eit edukovat pacienty o zdrav\u00E9m \u017Eivotn\u00EDm stylu."@cs . . "1" . . "1"^^ . "[0E5370EC01E1]" . "2"^^ . . "75/108" . "Diabetes and schizophrenia"@en . . .